[1]
Dash, R.P. et al. 2018. Non-alcoholic Steatohepatitis (NASH) Drug Discovery – Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. Journal of Pharmacy & Pharmaceutical Sciences. 21, 1 (Nov. 2018), 481–495. DOI:https://doi.org/10.18433/jpps30022.